My view - and sure people will slaughter it, they always do lol
Final data and uk presentation will be a non event share price wise aside from a little blip if traders want to push it.
The upward move and spiral rests with the EMA response to the 3rd and final meeting and hopefully the big tick heading into xmas with $0.08 esop and OB expiry out the way prior in mid december.
Ann: Positive preliminary results from ATL1102 DMD Phase II trial, page-589
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
